A carregar...
NCMP-23. FACIAL PALSY INDUCED BY CANCER IMMUNOTHERAPY: A SINGLE CENTER RETROSPECTIVE STUDY
Monoclonal antibodies to Cytotoxic T-lymphocyteassociated antigen 4 (CTLA-4) [ipilimumab] and programmed cell death (PD1) receptor or ligand (PDL1) [pembrolizumab, nivolumab, atezolizumab] are increasingly used for the treatment of metastatic cancer. The augmented immune response enabled by these ag...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216894/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.822 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|